Our new Cryptocurrency section has arrived! Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price: 7,316.00
Bid: 7,320.00
Ask: 7,323.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.04%)
Open: 7,431.00
High: 7,479.00
Low: 7,293.00
Yest. Close: 7,387.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

TOP NEWS: Astra, Merck Gets US Priority Review For Rare Genetic Drug

TOP NEWS: Astra, Merck Gets US Priority Review For Rare Genetic Drug

14 Nov 19 08:21

FDA accepts new drug application for AstraZeneca's selumetinib

(Sharecast News) - AstraZeneca, along with its partner MSD, announced on Thursday that the US Food and Drug Administration (FDA) has accepted a new drug application (NDA) and granted 'Priority Review' status for selumetinib, as a potential new medicine for paediatric patients aged three years and older with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas.

14 Nov 19 07:37

Tuesday broker round-up

(Sharecast News) - BBA Aviation: HSBC downgrades to hold with a target price of 330p.

12 Nov 19 13:31

Astra's Anifrolumab Shows Advantage Across Various Efficacy Endpoints

Astra's Anifrolumab Shows Advantage Across Various Efficacy Endpoints

12 Nov 19 08:56

AstraZeneca's anifrolumab succeeds in lupus study

(Sharecast News) - Biopharmaceutical giant AstraZeneca's anifrolumab demonstrated superiority across multiple efficacy endpoints versus placebos in the drug's Phase III TULIP 2 trial.

12 Nov 19 08:05

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance

11 Nov 19 10:22

UPDATE 1-Rising HK tensions drag Asia-exposed UK stocks

* FTSE 100 down 0.6%, FTSE 250 down 0.2%* Baker Greggs jumps after forecast upgrade* Stocks vulnerable to Asia sink on Hong Kong tensions (Adds company news items, analyst comment, updates share moves)By Muvija M and Shashwat AwasthiNov 11 (Reuters)...

11 Nov 19 09:26

LONDON MARKET OPEN: Stocks Lower But Sirius Minerals And Greggs Gain

LONDON MARKET OPEN: Stocks Lower But Sirius Minerals And Greggs Gain

11 Nov 19 08:43

TOP NEWS: AstraZeneca Reports Positive Test Results For Anaemia Drug

TOP NEWS: AstraZeneca Reports Positive Test Results For Anaemia Drug

11 Nov 19 08:07

AstraZeneca upbeat on latest roxadustat trial data

(Sharecast News) - AstraZeneca, along with its partner FibroGen, presented pooled efficacy and cardiovascular safety analyses from the pivotal phase 3 programme assessing 'roxadustat' on Monday, for the treatment of patients with anaemia from chronic kidney disease (CKD).

11 Nov 19 07:55

UPDATE 1-Safety data on AstraZeneca anaemia drug points to potential use in dialysis

(Adds quotes, further details about drug, potential sales)FRANKFURT, Nov 8 (Reuters) - AstraZeneca said that safety data on roxadustat underpinned the British drugmaker's hopes for the anaemia drug to become a standard treatment for patients with ...

8 Nov 19 19:52

Safety data on AstraZeneca anaemia drug points to potential use in dialysis

FRANKFURT, Nov 8 (Reuters) - AstraZeneca said on Friday that safety data on roxadustat underpinned the British drugmaker's hopes for the anaemia drug to become a standard treatment for patients with kidney disease.It said pooled data from several ...

8 Nov 19 19:47

AstraZeneca Drug Roxadustat Increases Haemoglobin Levels In Two Trials

AstraZeneca Drug Roxadustat Increases Haemoglobin Levels In Two Trials

8 Nov 19 08:14

AstraZeneca reports positive trials for kidney drug

(Sharecast News) - AstraZeneca on Friday reported clinical trials of its roxadustat drug for patients with anaemia from chronic kidney disease had significantly increased red haemoglobin levels.

8 Nov 19 07:50

Thursday broker round-up

(Sharecast News) - Associated British Foods: Goldman Sachs upgrades to buy with a target price of 2,750p.

7 Nov 19 13:28

Login to your account

Don't have an account? Click here to register.